Top Stories

PMLA case: Naresh Goyal, the founder of Jet Airways, requests temporary release due to cancer treatment

PMLA case: Naresh Goyal, the founder of Jet Airways, requests temporary release due to cancer treatment


PMLA case: Naresh Goyal, the founder of Jet Airways, requests temporary release due to cancer treatment



PMLA case: Naresh Goyal, the founder of Jet Airways, requests temporary release to get cancer treatment; the court creates a medical board to review the report.


Naresh Goyal, the founder of Jet Airways, said that tests performed by private physicians revealed the fatal illness.


Accused of money laundering, Naresh Goyal, the founder of Jet Airways, has filed a plea before a special court requesting temporary release so that he may get treatment for the fatal illness that private physicians tested him for.


As the ED requested more time to react to Goyal's temporary release request, the court issued a preliminary order establishing a medical board to review his medical report.


Goyal,74, was given permission by special judge MG Deshpande last month to have private physicians examine him for medical conditions under the Prevention of Money Laundering Act (PMLA).


The founder of Jet Airways, Goyal, said in his Thursday appeal for temporary release that tests performed by private physicians had revealed the fatal illness.


Goyal has "neuroendocrine tumors," or slow-growing cancer, in his gut, which is a frequent site for tiny tumors, according to his medical records.


Along with severe reflux esophagitis—a medical ailment that arises when the top section of the stomach protrudes through the diaphragm into the chest cavity—he also has a 35–40 cm hiatus hernia.


The recommended course of treatment for acid reflux is long-term medication or surgery to lower the stomach.


As part of Barrett's esophagus, a precancerous disease, their analysis also showed a tiny portion of constriction at the intersection of the middle and lower esophagus.


According to Goyal's application, his sample was submitted for immunohistochemistry and histological investigation.


In light of the results, it is impAccording to the petition, Irative Goyal will have a PET scan to ascertain the stage of the terminal illness. The doctor will then use this information to select the best course of treatment, which may include chemotherapy and surgery.Possess the ability to start.


According to the petition, the applicant's physicians have recommended vigorous and prompt treatment to avoid any potentially deadly consequences.


Sunil Gonsalves, the Special Public Prosecutor, proposed that the ED form a medical board at JJ Hospital and provide Goyal's medical records to the board for review. The ED would then provide a more detailed response.


Going on the test results and medical documents that Goyal's application included, Gonsalves said that the ED is not qualified to provide an opinion and submit a response based on those findings.


Goyal's attorney said that although he had no objections, the medical board need to be established right away to prevent the accused's health from being negatively impacted by the length of the legal proceedings.


Following a hearing from both parties, the court ordered the Dean of JJ Hospital to form a medical board at the ED's request to examine Goyal in great detail.


The medical board must provide the court with a definitive conclusion by February 20th, the judge said.


The board will investigate Goyal's medical records to determine the nature of his sickness and report back to the court on whether JJ Hospital offers the suggested course of therapy.


The ED detained the businessman in September 2023 on the grounds that he had embezzled funds and embezzled a ₹538.62 crore loan that Canara Bank had granted to Jet Airways.


The Central Bureau of Investigation (CBI) filed a formal complaint (FIR) in relation to a suspected bank fraud against Jet Airways, Goyal, his wife Anita, and a few former personnel of the now-defunct airline. This is the basis for the money laundering investigation.


No comments: